Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@TheRegenBio](/creator/twitter/TheRegenBio)
"$RGBP $RGBPP The company is currently in discussion on financing the Phase I clinical trials for HemaXellerate"  
[X Link](https://x.com/TheRegenBio/status/1973431729261257067) [@TheRegenBio](/creator/x/TheRegenBio) 2025-10-01T16:56Z 1860 followers, 665.7K engagements


"$RGBP $RGBPP Regen BioPharma is presenting at the Emerging Growth Conference on October XX 2025 at 4:10 pm Eastern. We will cover Orphan Drug status and HemaXellerate Clinical Phase I status. Also planning on answering questions from the audience"  
[X Link](https://x.com/TheRegenBio/status/1977735479438061851) [@TheRegenBio](/creator/x/TheRegenBio) 2025-10-13T13:57Z 1859 followers, 973.2K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TheRegenBio "$RGBP $RGBPP The company is currently in discussion on financing the Phase I clinical trials for HemaXellerate"
X Link @TheRegenBio 2025-10-01T16:56Z 1860 followers, 665.7K engagements

"$RGBP $RGBPP Regen BioPharma is presenting at the Emerging Growth Conference on October XX 2025 at 4:10 pm Eastern. We will cover Orphan Drug status and HemaXellerate Clinical Phase I status. Also planning on answering questions from the audience"
X Link @TheRegenBio 2025-10-13T13:57Z 1859 followers, 973.2K engagements

creator/twitter::1494008145831546882/posts
/creator/twitter::1494008145831546882/posts